时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
08:00-08:30 | 专题发言 |
女性生殖道肿瘤的预测和预后生物标志物: 临床相关性和实际问题的更新 |
|
|||
08:30-08:55 | 专题发言 |
女性生殖道的中肾腺癌与中肾样腺癌 |
|
|||
08:55-09:20 | 专题发言 |
深度分析20例伴有YWHAE重排的高级别子宫内膜间质肉瘤临床病理及分子遗传学特征 |
|
|||
09:20-09:45 | 专题发言 |
子宫内膜诊刮病理诊断室间质评分析 |
|
时间/Date | 类型/Type | 题目/Topic | 讲者/Speaker | 单位/Institution | ||
---|---|---|---|---|---|---|
09:45-09:52 | 发言交流 |
Lung adenocarcinoma metastatic to the ovary: a retrospective clinicopathological analysis of 17 cases and literature review |
|
|||
09:52-09:59 | 发言交流 |
卵巢浆-黏液性癌与卵巢内膜样癌临床病理学特征及免疫微环境差异性研究 |
|
|||
09:59-10:06 | 发言交流 |
MIRV靶向治疗卵巢、输卵管和腹膜高级别浆液性癌中FRα的免疫组化结果判读及注意事项 |
|
|||
10:06-10:13 | 发言交流 |
Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinicopathological and prognostic aspects in a Chinese single institution |
|
|||
10:13-10:20 | 发言交流 |
Synchronous carcinomas of endometrium and ovary or fallopian tubes: A genome-wide mutation analysis |
|
|||
10:20-10:27 | 发言交流 |
基于分子亚型探讨子宫内膜癌三级淋巴结构特征及意义 |
|
|||
10:27-10:34 | 发言交流 |
子宫内膜不典型增生及Ia期子宫内膜癌保留生育功能治疗的疗效及影响因素分析 |
|
|||
10:34-10:41 | 发言交流 |
回顾性分析2023年FIGO子宫内膜癌新分期纳入分子分型后对癌症分期的影响 |
|
|||
10:41-10:48 | 发言交流 |
子宫内膜癌中P53免疫组化染色结果与NGS检测TP53突变状态的一致性分析 |
|
|||
10:48-10:55 | 发言交流 |
The analysis of clinicopathologic and molecular features of microcystic, elongated and fragmented pattern invasion, in endometrioid endometrial cancer |
|
|||
10:55-11:02 | 发言交流 |
Immunohistochemical expression and clinical significance of PD-L1 and SSTR2 in neuroendocrine carcinoma of the cervix |
|
|||
11:02-11:09 | 发言交流 |
FOXL2突变的卵巢成人型颗粒细胞瘤临床病理分析及I期患者复发预测模型的建立 |
|
|||
11:09-11:16 | 发言交流 |
卵巢支持‐间质细胞肿瘤临床病理学及分子遗传学特征分析 |
|
|||
11:16-11:23 | 发言交流 |
Clinicopathological featuresand molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor |
|
|||
11:23-11:30 | 发言交流 |
基于疑难病例会诊的子宫罕见间叶性肉瘤临床病理诊断及鉴别诊断分析 |
|